In a report published Wednesday, Cantor Fitzgerald analyst Jeremy Feffer reiterated a Hold rating on Align Technology ALGN, and raised the price target from $35.00 to $40.00.
In the report, Cantor Fitzgerald noted, “With ALGN reporting 2Q:13 EPS AMC on 7/18, we provide our updated thoughts on recent developments and a preview of 2Q results. ALGN has enjoyed a string of positive catalysts in recent months, including above-consensus 1Q results, a favorable ruling on ClearCorrect patient infringement, and the Henry Schein partnership. Given the recent momentum and our expectation that 2Q comes in at or above the high end of guidance, we are raising our price target from $35 to $40 (15x 2014E EV/EBTIDA), but we maintain our HOLD rating due to our ongoing concern over pricing and a GP dentist segment that is stable but recovering slowly.”
Align Technology closed on Tuesday at $38.19.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in